The evidence-based pathway for peri-operative management of open and robotically assisted laparoscopic radical prostatectomy

BJU International

Volumn 99, Issue 5, 2007, Pages 1103-1108

  Kaufman, Melissa R ^a   Baumgartner, Roxelyn G ^a   Anderson, Laura W ^a   Smith Jr , Joseph A ^a   Chang, Sam S ^a   Herrell, S Duke ^a   Cookson, Michael S ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical pathway; Collaborative care; Evidence based medicine; Laparoscopic; Prostatectomy; Robotic

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFAZOLIN; CLINDAMYCIN; ESOMEPRAZOLE; FAMOTIDINE; HEPARIN; KETOROLAC; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; NEOMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATHETER REMOVAL; CLINICAL TRIAL; COMPRESSION THERAPY; COMPUTER ASSISTED SURGERY; DEEP VEIN THROMBOSIS; DIET; EVIDENCE BASED PRACTICE; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTESTINE PREPARATION; LABORATORY TEST; LAPAROSCOPIC SURGERY; MEDLINE; META ANALYSIS; NONHUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; PROSTATECTOMY; RECTUM INJURY; ROBOTICS; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME;

BLOOD LOSS, SURGICAL; DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; LAPAROSCOPY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS; TREATMENT OUTCOME;

EID: 34247161718     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06777.x     Document Type: Article

References (54)

1. Koch MO, Smith JA Jr. Clinical outcomes associated with the implementation of a cost-efficient programme for radical retropubic prostatectomy. Br J Urol 1995; 76: 28-33
2. Koch MO, Smith JA Jr, Hodge EM, Brandell RA. Prospective development of a cost-efficient program for radical retropubic prostatectomy. Urology 1994; 44: 311-8
3. Kaufman MR, Smith JA Jr, Baumgartner RG et al. Positive influence of robotically assisted laparoscopic prostatectomy on the collaborative-care pathway for open radical prostatectomy. BJU Int 2006; 97: 473-5
4. Dahm P, Scales CD, Sur RL, Preminger GM. An introduction to evidence-based medicine for urologists. AUA Update Series 2006: 25
5. O'Connor PJ. Adding value to evidence-based clinical guidelines. JAMA 2005; 294: 741-3
6. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Clin Infect Dis 2004; 38: 1706-15
7. Peters CA, Walsh PC. Blood transfusion and anesthetic practices in radical retropubic prostatectomy. J Urol 1985; 134: 81-3
8. Smith JA Jr. Robotically assisted laparoscopic prostatectomy: an assessment of its contemporary role in the surgical management of localized prostate cancer. Am J Surg 2004; 188(Suppl.): 63S-67S
9. Koch MO, Smith JA Jr. Blood loss during radical retropubic prostatectomy: is preoperative autologous blood donation indicated? J Urol 1996; 156: 1077-80
10. Chang SS, Duong DT, Wells N, Cole EE, Smith JA Jr, Cookson MS. Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index. J Urol 2004; 171: 1861-5
11. Nieder AM, Rosenblum N, Lepor H. Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. Urology 2001; 57: 737-41
12. Pasternak LR. Preoperative laboratory testing: general issues and considerations. Anesthesiol Clin North America 2004; 22: 13-25
13. Mantha S, Roizen MF, Madduri J, Rajender Y, Shanti Naidu K, Gayatri K. Usefulness of routine preoperative testing: a prospective single-observer study. J Clin Anesth 2005; 17: 51-7
14. Eagle KA, Berger PB, Calkins H et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 2002; 105: 1257-67
15. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335: 1713-20
16. Chassot PG, Delabays A, Spahn DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Br J Anaesth 2002; 89: 747-59
17. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003; 97: 623-33
18. Schouten O, Shaw LJ, Boersma E et al. A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coron Artery Dis 2006; 17: 173-9
19. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-61
20. Poldermans D, Boersma E. Beta-blocker therapy in noncardiac surgery. N Engl J Med 2005; 353: 412-4
21. Overend TJ, Anderson CM, Lucy SD, Bhatia C, Jonsson BI, Timmermans C. The effect of incentive spirometry on postoperative pulmonary complications: a systematic review. Chest 2001; 120: 971-8
22. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126(Suppl.): 338S-400S
23. Heit JA, O'Fallon WM, Petterson TM et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-8
24. Goldhaber SZ. Prevention of pulmonary embolism in patients undergoing urologic surgery. AUA Update Series 2004: 17
25. Copeland DC, Gretzer MB. Deep venous thrombosis: evidence-based prevention strategies. Contemporary Urology 2006: 48-54
26. Montgomery JS, Wolf JS Jr. Venous thrombosis prophylaxis for urological laparoscopy: fractionated heparin versus sequential compression devices. J Urol 2005; 173: 1623-6
27. Koch MO, Smith JA Jr. Low molecular weight heparin and radical prostatectomy: a prospective analysis of safety and side effects. Prostate Cancer Prostatic Dis 1997; 1: 101-4
28. Bigg SW, Catalona WJ. Prophylactic mini-dose heparin in patients undergoing radical retropubic prostatectomy. A prospective trial. Urology 1992; 39: 309-13
29. Sieber PR, Rommel FM, Agusta VE et al. Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy? J Urol 1997; 158: 869-71
30. Bergqvist D, Agnelli G, Cohen AT et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346: 975-80
31. Delaney CP, Zutshi M, Senagore AJ, Remzi FH, Hammel J, Fazio VW. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 2003; 46: 851-9
32. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg 2002; 183: 630-41
33. Wilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ 2001; 322: 473-6
34. Cepeda MS, Carr DB, Miranda N, Diaz A, Silva C, Morales O. Comparison of morphine, ketorolac, and their combination for postoperative pain: results from a large, randomized, doubleblind trial. Anesthesiology 2005; 103: 1225-32
35. See WA, Fuller JR, Toner ML. An outcome study of patient-controlled morphine analgesia, with or without ketorolac, following radical retropubic prostatectomy. J Urol 1995; 154: 1429-32
36. Kay G, Campbell R, Bukala B, Almeida S, Razvi H. The role of ketorolac tromethamine in a clinical care pathway for men undergoing radical retropubic prostatectomy. Urol Nurs 2002; 22: 392-3, 396-7, 426
37. Webster TM, Herrell SD, Chang SS et al. Robotic assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: a prospective assessment of postoperative pain. J Urol 2005; 174: 912-4
38. Green D, Klement P, Liao P, Weitz J. Interaction of low molecular weight heparin with ketorolac. J Lab Clin Med 1996; 127: 583-7
39. Forrest JB, Camu F, Greer IA et al. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth 2002; 88: 227-33
40. Henzi I, Walder B, Tramer MR. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth 1999; 83: 761-71
41. Hiramoto JS, Terdiman JP, Norton JA. Evidence-based analysis: postoperative gastric bleeding: etiology and prevention. Surg Oncol 2003; 12: 9-19
42. Rosenblum N, Lepor H. Radical retropubic prostatectomy. Preoperative management. Urol Clin North Am 2001; 28: 499-507
43. Lepor H. Practical considerations in radical retropubic prostatectomy. Urol Clin North Am 2003; 30: 363-8
44. Nichols RL, Broido P, Condon RE, Gorbach SL, Nyhus LM. Effect of preoperative neomycin-erythromycin intestinal preparation on the incidence of infectious complications following colon surgery. Ann Surg 1973; 178: 453-62
45. Nichols RL, Choe EU, Weldon CB. Mechanical and antibacterial bowel preparation in colon and rectal surgery. Chemotherapy 2005; 51 (Suppl. 1): 115-21
46. Ferguson KH, McNeil JJ, Morey AF. Mechanical and antibiotic bowel preparation for urinary diversion surgery. J Urol 2002; 167: 2352-6
47. Lepor H, Nieder AM, Fraiman MC. Early removal of urinary catheter after radical retropubic prostatectomy is both feasible and desirable. Urology 2001; 58: 425-9
48. Nieder AM, Manoharan M, Kim SS, Soloway MS. Neither ?-blocker therapy nor cystography is required before early catheter removal after radical prostatectomy. BJU Int 2005; 95: 323-5
49. Santis WF, Hoffman MA, Dewolf WC. Early catheter removal in 100 consecutive patients undergoing radical retropubic prostatectomy. BJU Int 2000; 85: 1067-8
50. Koch MO, Nayee AH, Sloan J et al. Early catheter removal after radical retropubic prostatectomy: long-term followup. J Urol 2003; 169: 2170-2
51. Tiguert R, Rigaud J, Fradet Y. Safety and outcome of early catheter removal after radical retropubic prostatectomy. Urology 2004; 63: 513-7
52. Patel R, Lepor H. Removal of urinary catheter on postoperative day 3 or 4 after radical retropubic prostatectomy. Urology 2003; 61: 156-60
53. Noguchi M, Shimada A, Yahara J, Suekane S, Noda S. Early catheter removal 3 days after radical retropubic prostatectomy. Int J Urol 2004; 11: 983-8
54. Mansson W. Evidence-based urology - a utopia? Eur Urol 2004; 46: 143-6